O-Mannose glycans, a family of highly heterogeneous complex glycans account up to 30% of total O-glycans in brain. Previous synthesis and functional studies only focused on the Core M3 O-mannose glycans of α-dystroglycan which are a causative factor for various muscular diseases. In this study, a highly efficient chemoenzymatic strategy was developed that enabled the first collective synthesis of 63 Core M1 and Core M2 O-mannose glycans. This chemoenzymatic strategy features the gram-scale chemical synthesis of 5 judiciously designed core structures, and the diversity-oriented modification of the core structures with 3 enzyme modules to provide 58 complex O-mannose glycans in a linear sequence that does not exceed 4 steps. Of note, 55 of these O-mannose glycans are synthesized for the first time. Using the printed O-mannose glycan array, the human brain protein CD33, a key factor in the modulation of Alzheimer’s disease was identified as strongly binding to sialylated Core M1 and Core M2.